The safety of modern, bioidentical HRT
Today’s Hormone Replacement Therapy (HRT) options have undergone significant advancements, particularly with the use of bioidentical hormones, which are chemically identical to those naturally produced by the body. This has greatly minimized the risks that were associated with older forms of HRT. Here’s a breakdown of the most common concerns:
- Breast Cancer: While there is a slight increase in breast cancer risk for women using combined estrogen-progestin therapy, this risk is minimal and diminishes after stopping treatment. For women who’ve had a hysterectomy, estrogen-only therapy is associated with a lower risk of breast cancer. Using bioidentical hormones further reduces this risk compared to synthetic hormones.
- Heart Health: Contrary to earlier studies, modern research shows that starting HRT early (before age 60 or within 10 years of menopause) does not increase heart disease risk—in fact, it may help protect heart health. The timing of HRT is critical for reducing cardiovascular risks.
- Blood Clots: The risk of developing blood clots, a concern with oral forms of HRT, is significantly reduced with transdermal options such as patches, gels, or sprays. These delivery methods bypass the liver, lowering the risk of blood clots and making them a safer option for many women.
With these improved formulations and delivery methods, HRT is much safer than it was in the past.
Why timing matters
Starting HRT during perimenopause or early menopause can have life-changing benefits. Delaying HRT could increase the risk of frailty and dementia as well as osteoporosis and heart disease. Early intervention helps preserve bone density, protects your heart, and maintains cognitive function. By starting HRT early, you reduce the chances of being affected by conditions like dementia or debilitating fractures, ensuring a more active and fulfilling life.